Clinical Trial Update: Safety and Effectiveness of the Device "Nit-Occlud® PDA-R" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results and safety assessment for the Nit-Occlud PDA-R device in closing patent ductus arteriosus in congenital heart disease; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Patent Ductus Arteriosus

Drugs mentioned

• Nit-Occlud PDA-R

Snippet

Sponsor: pfm S.R.L. | Conditions: Congenital Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-05-24